Skip to main content
. 2016 Aug 10;8(15):517–532. doi: 10.4253/wjge.v8.i15.517

Table 4.

Clinical outcomes among patients with gastric cancers who underwent endoscopic submucosal dissection

Outcomes Studies, n Tumor, n Rate (95%CI)1
Efficacy measures
R0 resection 24 8520 87 (84-90)
Endoscopic en bloc resection 29 9652 94 (91-96)
Curative resection 10 5234 83 (80-86)
Safety measures
Immediate perforation2 31 12076 3.1 (2.4-3.9)
Immediate major bleeding2 6 303 2.9 (0.24-27)
Delayed perforation3 6 1486 0.15 (0.01-3.8)
Delayed bleeding3 29 11925 3.8 (3.0-4.7)
Recurrence (if R0)4 8 724 0.14 (0.004-4.6)
Recurrence (if not R0)4 7 152 8.5 (3.6-19)
Recurrence (irrespective of R0 status)4 18 7681 0.77 (0.39-1.5)
1

The rates are calculated as a percentage of the total number of tumors operated;

2

Immediate refers to adverse outcomes occurring within 24 h of the procedure;

3

Delayed refers to adverse outcome occurring 24 h after the procedure;

4

Average follow-up was about 26, 24 and 37 mo for assessment of recurrence among tumors with R0, without R0, and irrespective of R0 status respectively. R0: Histologically-confirmed en bloc resection.